| Literature DB >> 29358441 |
Shannon M Fernando1, David Neilipovitz1, Aimee J Sarti1, Erin Rosenberg1, Rabia Ishaq1, Mary Thornton1, John Kim1.
Abstract
INTRODUCTION: Patients admitted to a critical care medicine (CCM) environment, including an intensive care unit (ICU), are susceptible to harm and significant resource utilisation. Therefore, a strategy to optimise provider performance is required. Performance scorecards are used by institutions for the purposes of driving quality improvement. There is no widely accepted or standardised scorecard that has been used for overall CCM performance. We aim to improve quality of care, patient safety and patient/family experience in CCM practice through the utilisation of a standardised, repeatable and multidimensional performance scorecard, designed to provide a continuous review of ICU physician and nurse practice, as well as departmental metrics. METHODS AND ANALYSIS: This will be a mixed-methods, controlled before and after study to assess the impact of a CCM-specific quality scorecard. Scorecard metrics were developed through expert consensus and existing literature. The study will include 19 attending CCM physicians and approximately 300 CCM nurses. Patient data for scorecard compilation are collected daily from bedside flow sheets. Preintervention baseline data will be collected for 6 months for each participant. After this, each participant will receive their scorecard measures. Following a 3-month washout period, postintervention data will be collected for 6 months. The primary outcome will be change in performance metrics following the provision of scorecard feedback to subjects. A cost analysis will also be performed, with the purpose of comparing total ICU costs prior to implementation of the scorecard with total ICU costs following implementation of the scorecard. The qualitative portion will include interviews with participants following the intervention phase. Interviews will be analysed in order to identify recurrent themes and subthemes, for the purposes of driving scorecard improvement. ETHICS AND DISSEMINATION: This protocol has been approved by the local research ethics board. Publication of results is anticipated in 2019. If this intervention is found to improve patient- and unit-directed outcomes, with evidence of cost-effectiveness, it would support the utilisation of such a scorecard as a quality standard in CCM. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.Entities:
Keywords: qualitative research; quality in health care
Mesh:
Year: 2018 PMID: 29358441 PMCID: PMC5781100 DOI: 10.1136/bmjopen-2017-019165
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Validated tools for scorecard inclusion
| Variable | Tool to be used |
| Pain (for patients that can self-report) | Numeric Rating Scale, Visual Analogue Scale |
| Pain (for patients that are unable to self-report) | Critical Care Pain Observation Tool |
| Delirium | Confusion Assessment Measurement for the Intensive Care Unit (ICU) |
| Sedation | Richmond Agitation and Sedation Scale |
| Mobility | ICU Mobility Scale |
| Mechanical ventilation weaning | Spontaneous breathing trials |
| Fluid balance in acute lung injury | Conservative fluid strategy |
| Blood glucose management | Avoidance of hyperglycaemia |
| Physician feedback | Ottawa assessment tool |
| Family and patient satisfaction | Ottawa assessment tool |
Variables for inclusion in the scorecard will be measured using evidence-based, validated clinical tools from the critical care literature.
Figure 1Study flow. Flow of physician subjects through the study. Data will be collected 6 months prior to the intervention (the initial provision of scorecard data to subjects). Following the intervention, there will be a 3-month washout phase, where no data will be collected. After this washout phase, postintervention data will be gathered for 6 months. Subjects will continue to receive scorecard data on a quarterly basis.
Performance scorecard
| Measure | Individual score | Population median score | Target score |
| Mortality (%) | |||
| Efficiency | |||
| No. of admitted patients/day | |||
| No. of patients discharged/day | |||
| Sensorium | |||
| % of CAM+ patients | |||
| % of CAM+ patients receiving sedation | |||
| % of patients with RASS score −4 or −5 | |||
| Analgesia | |||
| CPOT daily score | |||
| % of patients with CPOT >2 | |||
| Mobilisation score | |||
| Ventilation and weaning | |||
| % of patients maintained on ventilator | |||
| Extubation % | |||
| Reintubation rate <48 hours after planned extubation | |||
| % SBT of ventilated patients | |||
| Fluid balance | |||
| Median fluid balance | |||
| Median fluid balance/24 hours | |||
| Prevention | |||
| % patient days with blood glucose >12 | |||
| % patient days with central line | |||
| % patient days receiving nutrition | |||
| Physician feedback | |||
| Ottawa assessment tool score | |||
| Family/patient satisfaction | |||
| Ottawa assessment tool score |
An example of the proposed scorecard, including the subject’s individual score, the population median score and the ideal target score.
CAM, Confusion Assessment Measurement; CPOT, Critical Care Pain Observation Tool; RASS, Richmond Agitation and Sedation Scale; SBT, Spontaneous Breathing Trial.